- Code of Federal Regulations 21 CFR 50 - Protection of Human Subjects
- Current Good Manufacturing Practice In Manufacturing, Processing, Packing or Holding of Drugs; General 21 CFR 210
- Current Good Manufacturing Practice for Finished Pharmaceuticals 21 CFR 211
- Drugs for Human Use 21 CFR 314
- Bioavailability and Bioequivalence Requirements 21 CFR 320
- Over-The-Counter (OTC) Human Drugs Which are Generally Recognized as Safe and Effective and Not Misbranded 21 CFR 330
- Biologics Licensing 21 CFR 601
Links:
[1] https://hso.research.uiowa.edu/viii-additional-references
[2] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=50
[3] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=210
[4] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=211
[5] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=314
[6] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=320
[7] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=330
[8] http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=601